Skip to main content
. 2021 Feb 16;291:114102. doi: 10.1016/j.jviromet.2021.114102

Table 3.

– Results overview of the examined assays.

Examined samples cobas® SARS-CoV-2 (Roche) Allplex™ 2019-nCoV Assay (Seegene) SARS-CoV-2 AMP Kit (Abbott) RealStar® SARS-CoV-2 RT-PCR Kit 1.0 (altona) Xpress Xpert® SARS-CoV-2 (Cepheid) Vivalytic VRI Panel (Schnelltest COVID-19) (Bosch)
Dilution series panel (highest dilution where SARS-CoV-2-RNA was detected in) 10−5 10−9,5 (N gene only) 10−8.5 10−7
(S gene only)
10−8 (N2 gene only) 10−4
Selected clinical samples (detected) ✓(8/8) ✓(8/8***) ✓(8/8) ✓(5/5) (✓)(6/8)
EQA samples (correctly determined) ✓(12/12) (✓)(11/12) ✓ (5/5) (✓)(4/5) ✓(7/7) ✓(7/7**)
Other Coronaviruses (correctly not detected/identified)**** ✓(4/4) ✓(4/4) ✓(4/4) ✓(2/2) ✓(4/4*****)

*only the 10−3 sample was tested.

**one sample was detected as “Sarbeco-related”.

***one sample was only detected in the N gene.

****SARS-CoV-1 (2003 outbreak) excluded.

*****MERS-CoV was detected as “SARS-related”.

- not tested.

✓perfect performance (all samples were determined correctly).

(✓) good performance (nearly all samples were determined correctly).